Addison Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Addison Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$713	Buy	+18	New	+$644	﹤0.01%	709
2023 Q2	–	Sell	-1,023	Closed	-$9.05K	–	655
2023 Q1	$9.05K	Hold	1,023	–	–	0.01%	468
2022 Q4	$9.33K	Hold	1,023	–	–	0.01%	449
2022 Q3	$8K	Hold	1,023	–	–	0.01%	462
2022 Q2	$8K	Sell	1,023 -240	-19%	-$2.09K	﹤0.01%	462
2022 Q1	$12K	Buy	1,263 +1,023	+426%	+$8.54K	0.01%	459
2021 Q4	$2K	Buy	+240	New	+$2.17K	﹤0.01%	546

Other funds holding TEVA

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Addison Advisors's TEVA Position: Q3 2026 in Review

Addison Advisors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 18 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #709 among its holdings. This is a return to the name: Addison Advisors previously reported a position in TEVA as recently as Q1 2023.

Addison Advisors first reported a position in TEVA in Q4 2021 and has held it in 7 quarters since. The position peaked at $12K in Q1 2022. 327 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Addison Advisors held 18 shares of Teva Pharmaceutical Industries Limited worth $713 as of Q3 2026.
Teva Pharmaceutical Industries Limited was a new Addison Advisors position in Q3 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Addison Advisors's portfolio in Q3 2026, its #709 holding.
Addison Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2021 and has held it in 7 quarters since.
Addison Advisors's Teva Pharmaceutical Industries Limited position peaked at $12K in Q1 2022.
327 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Addison Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.